CDKN2A and head and neck squamous cell carcinoma: In OSCC, CDKN2A loss of expression was associated with the disease recurrence (Deepak Roshan et al., 2019), and p16 as one of the well-accepted markers of HNSCC prognosis positively correlated with better disease outcomes (reviewed in Augustin et al., 2020).